Polycystic ovary syndrome affects a wide range of body systems, reaching well beyond the ovaries themselves. The condition is driven largely by excess androgens, insulin resistance, and chronic low-grade inflammation, and the symptoms it produces span from irregular periods and unwanted hair growth to significantly elevated risks for type 2 diabetes, cardiovascular disease, liver disease, and certain cancers. Not every person with PCOS develops the same set of problems, though, because the syndrome shows up in distinct patterns that shift which health risks take center stage.
The Hormonal Core and How It Shows Up on the Surface
PCOS is diagnosed when at least two of three features are present: signs of excess androgens (either from blood tests or visible changes like acne and facial hair), irregular or absent ovulation, and ovaries that appear polycystic on ultrasound, provided other conditions have been ruled out.1Endocrine and Metabolic Science. The last update on polycystic ovary syndrome(PCOS), diagnosis criteria, and novel treatment – Section: Current recommendations This means someone can have PCOS without actually having cysts on their ovaries, which is one of the most common sources of confusion around the name.
The androgen excess is responsible for many of the most visible symptoms. Hirsutism, the growth of coarse, dark hair in areas like the chin, upper lip, chest, and abdomen, affects roughly 65 to 75 percent of women with PCOS, compared with about 4 to 11 percent of the general female population.2PubMed Central. Hirsutism, Normal Androgens and Diagnosis of PCOS The same hormonal shifts can trigger persistent acne, thinning hair on the scalp, and oily skin. These are not cosmetic inconveniences layered on top of an otherwise hidden condition; for many people, they are the reason they seek medical attention in the first place.
Behind the scenes, signals from the brain are part of the problem. The hypothalamus fires pulses of a hormone called GnRH at an abnormally fast rate, which pushes the pituitary gland to release too much LH relative to FSH.3PubMed Central. Neuroendocrine dysfunction in polycystic ovary syndrome That LH imbalance drives the ovaries to overproduce androgens and disrupts the normal cycle of egg maturation and release, which is why irregular or missing periods are so common.4PubMed Central. Central Regulation of PCOS: Abnormal Neuronal-Reproductive-Metabolic Circuits in PCOS Pathophysiology
Insulin Resistance and the Road to Type 2 Diabetes
Insulin resistance is one of the most consequential features of PCOS, and it appears to be baked into the condition itself rather than being solely a consequence of carrying extra weight. Research on lean women with PCOS has shown that insulin resistance is present regardless of obesity.5PubMed Central. Lean polycystic ovary syndrome (PCOS): an evidence-based practical approach – Section: RESULTS When your cells respond poorly to insulin, the pancreas pumps out more of it to compensate. That excess insulin stimulates the ovaries to make even more androgens, creating a feedback loop that worsens the hormonal imbalance.
Over time, this insulin resistance accelerates the slide toward impaired glucose tolerance and type 2 diabetes. An eight-year follow-up study found that the incidence of type 2 diabetes in women with PCOS was about 13 percent compared with roughly 6 percent in controls, giving PCOS an overall relative risk of about 2.3. When obesity was also present, the risk jumped to fivefold.6PubMed. Risk of T2DM and impaired fasting glucose among PCOS subjects: results of an 8-year follow-up Another study tracked women who started with normal blood sugar and found that about 12 percent of those with PCOS progressed to impaired glucose tolerance, with an annualized conversion rate of roughly 4.5 percent, faster than what was observed in healthy women.7PubMed. Progression to impaired glucose tolerance or type 2 diabetes mellitus in polycystic ovary syndrome: a controlled follow-up study These glucose problems show up more frequently in PCOS even after accounting for differences in body weight.8PubMed Central. Polycystic ovary syndrome and type 2 diabetes mellitus: A state-of-the-art review
The practical takeaway is that regular blood-sugar screening matters for anyone with PCOS, not just those who are overweight. Guidelines typically recommend testing for diabetes or prediabetes at the time of diagnosis and periodically afterward.
Cardiovascular Risk and What the Numbers Actually Show
PCOS stacks up several well-known cardiovascular risk factors: unfavorable cholesterol profiles, higher blood pressure, and thickened artery walls. A study of women with PCOS over age 30 found that they had higher LDL cholesterol, higher triglycerides, lower HDL cholesterol, and greater arterial wall thickness compared to controls, even after adjusting for differences in body mass.9PubMed Central. Predictors of subclinical cardiovascular disease in women with polycystic ovary syndrome: interrelationship of dyslipidemia and arterial blood pressure These are all markers that cardiologists associate with early atherosclerosis.
The question has always been whether these risk factors translate into actual heart attacks and strokes, or whether they remain “subclinical” without ever causing events. A large study tracking outcomes over 25 years found that they do translate. Women with PCOS had about a 50 to 60 percent higher risk of heart attack and ischemic stroke after adjusting for other factors. The absolute numbers were still low, with a 25-year cumulative incidence of about 3.4 percent in the PCOS group versus 2 percent in controls, but the relative increase was consistent and statistically clear.10PubMed. Polycystic ovarian syndrome and long-term risk of acute myocardial infarction and ischaemic stroke The low absolute risk is worth emphasizing: PCOS is not a cardiovascular emergency, but it does justify earlier and more proactive screening for blood pressure, cholesterol, and blood sugar than you might otherwise receive at a young age.
Fatty Liver Disease
Non-alcoholic fatty liver disease has emerged as one of the more underappreciated consequences of PCOS. The shared thread of insulin resistance makes the connection unsurprising, but the magnitude of the association is still striking. A large hospital-based analysis found that women with PCOS had about four times the odds of having fatty liver disease after adjusting for obesity, diabetes, high cholesterol, and high blood pressure.11Hepatology. Association of non-alcoholic fatty liver disease and polycystic ovarian syndrome – Section: Results
A UK primary-care database study supported a similar picture: PCOS roughly doubled the rate of new fatty liver diagnoses over follow-up, and this held even in women with a normal body weight.12PLoS Medicine. Polycystic ovary syndrome, androgen excess, and the risk of nonalcoholic fatty liver disease in women: A longitudinal study based on a United Kingdom primary care database – Section: Results Androgen excess appears to play an independent role on top of insulin resistance in driving fat accumulation in the liver.13PubMed Central. Nonalcoholic fatty liver disease and polycystic ovary syndrome Because fatty liver can silently progress to inflammation and scarring over years, this is another area where awareness and periodic liver function testing can make a difference.
Endometrial Cancer and Other Gynecologic Cancer Risks
When ovulation does not happen regularly, the uterine lining is exposed to estrogen month after month without the counterbalancing effect of progesterone that normally follows egg release. Over years, this unopposed estrogen exposure promotes thickening and abnormal growth of the endometrium.14PubMed Central. Are women with PCOS more at risk for endometrial cancer? What approach for such patients? A meta-analysis calculated the endometrial cancer risk in PCOS at roughly 2.8 times that of women without the syndrome, and the risk was even higher when the analysis was limited to women under 54.15Human Reproduction Update. Risk of endometrial, ovarian and breast cancer in women with polycystic ovary syndrome: a systematic review and meta-analysis – Section: Results
The picture for ovarian cancer is less clear-cut. The same meta-analysis found no significant increase overall, but did find a significant rise when younger women were analyzed separately.15Human Reproduction Update. Risk of endometrial, ovarian and breast cancer in women with polycystic ovary syndrome: a systematic review and meta-analysis – Section: Results A more recent review found a modest increase in ovarian cancer odds in PCOS, while another noted that genetic studies have actually suggested a reduced risk.16PubMed Central. Risk of endometrial, ovarian, and breast cancers in women with polycystic ovary syndrome: A systematic review and meta-analysis – Section: Results17PubMed Central. Risk of Gynecological Cancers in Women With Polycystic Ovary Syndrome and the Pathophysiology of Association As for breast cancer, the evidence consistently shows no significant increase in risk with PCOS.
The practical implication is that endometrial health deserves real attention. If you have PCOS and go many months without a period, a doctor will often prescribe periodic progesterone or a hormonal contraceptive to trigger a withdrawal bleed and protect the uterine lining from unopposed estrogen buildup.
Pregnancy Complications
When people with PCOS do conceive, the pregnancy carries higher-than-average risks of certain complications. A large national register study found that women with PCOS alone had about 18 percent higher odds of preeclampsia and about 34 percent higher odds of preterm birth compared to women without PCOS. When gestational diabetes was present alongside PCOS, those odds roughly doubled.18PubMed Central. Polycystic ovary syndrome and gestational diabetes mellitus association to pregnancy outcomes: A national register-based cohort study – Section: RESULTS Gestational diabetes itself is more common in PCOS pregnancies, largely because the underlying insulin resistance provides a head start toward the glucose dysregulation that pregnancy hormones can trigger.
These risks do not make pregnancy with PCOS dangerous, but they do shift it into a category that benefits from closer monitoring. Early glucose tolerance testing, frequent blood pressure checks, and awareness of preeclampsia warning signs become more important.
Mental Health and Quality of Life
Depression and anxiety are significantly more common in people with PCOS, and their impact on daily life can rival or exceed that of the metabolic complications. Studies consistently find higher depression and anxiety scores in women with PCOS compared to controls, along with reduced quality-of-life measures, with infertility concerns and weight-related distress having the largest negative effects.19PubMed. Androgen Excess- Polycystic Ovary Syndrome Society: position statement on depression, anxiety, quality of life, and eating disorders in polycystic ovary syndrome The association extends to bipolar disorder and eating disorders as well.20PubMed Central. Bridging the Gap: Integrating Awareness of Polycystic Ovary Syndrome Into Mental Health Practice
What makes this especially frustrating is that the relationship likely runs in multiple directions. Excess androgens and insulin resistance may directly affect brain chemistry. At the same time, living with visible symptoms like hirsutism and acne, struggling with fertility, and managing weight that seems disproportionately resistant to effort all take a real psychological toll. Recognizing that mental health is a clinical dimension of PCOS, not a side issue, is something the medical field has been slow to do but is gradually improving on.
Sleep Apnea
Obstructive sleep apnea shows up at higher rates in PCOS than you would expect for premenopausal women, who are otherwise at relatively low risk for it. The connection appears to involve several converging factors: higher androgen levels, increased abdominal fat, and the metabolic dysfunction that characterizes the condition.21PubMed Central. Polycystic Ovary Syndrome and Obstructive Sleep Apnea A study that tried to tease apart which metabolic features best predicted sleep apnea risk in PCOS found that blood sugar control, systemic inflammation, and androgen status were independent contributors.22PubMed Central. Metabolic and endocrine status associate with obstructive sleep apnea risk among patients with polycystic ovary syndrome
Sleep apnea matters beyond just poor sleep quality because it independently worsens insulin resistance and cardiovascular risk, compounding the problems PCOS already creates. If you have PCOS and experience daytime sleepiness, snoring, or waking up feeling unrefreshed, it is worth discussing a sleep evaluation with your doctor.
Chronic Low-Grade Inflammation
Running beneath many of these complications is a state of chronic low-grade inflammation that is now recognized as a core feature of PCOS, not just a side effect of obesity. Women with PCOS show elevated levels of inflammatory markers like C-reactive protein and white blood cell counts compared to healthy controls.23PubMed Central. Inflammatory Markers in Women with Polycystic Ovary Syndrome – Section: Results A systematic review examining 44 studies identified dozens of different inflammatory biomarkers that tend to be elevated in PCOS, with a meta-analysis confirming significantly higher levels of the inflammatory cytokine IL-6 in PCOS patients.24PubMed Central. A Systematic Review of Inflammatory Markers in Polycystic Ovary Syndrome (PCOS) and Meta-Analysis of Interleukin-6 (IL-6) in Case-Control Studies
This inflammation contributes to insulin resistance, accelerates arterial damage, promotes liver fat deposition, and may worsen ovarian dysfunction. It helps explain why the health consequences of PCOS reach so far beyond reproduction.
Not Everyone Gets the Same Version
One of the more important things to understand about PCOS is that it is not a single uniform condition. Research has identified distinct clinical phenotypes with meaningfully different hormone profiles and health risks. A cross-sectional study found that one phenotype was characterized mainly by neuroendocrine dysfunction with high LH, excess androgens, and infertility. A second was dominated by obesity, insulin resistance, and a skin condition called acanthosis nigricans, with relatively less hormonal disruption. A third had regular cycles but more prominent acne and hirsutism.25PubMed Central. Clinical Phenotypes of PCOS: a Cross-Sectional Study – Section: Results
This variation is clinically meaningful. Someone in the insulin-resistant, obesity-predominant group faces a very different risk profile than someone whose main problem is irregular ovulation with mild androgen excess. It also explains why some people with PCOS feel that their experience bears little resemblance to what they read online: the syndrome genuinely manifests differently across individuals. Treatment, ideally, should target whichever features are most prominent in a given person rather than follow a one-size-fits-all protocol.
The Gut Microbiome Connection
An emerging area of research links PCOS to changes in the gut microbiome. The idea is that an imbalanced microbial community in the intestines may contribute to PCOS symptoms through the metabolites bacteria produce, including bile acids, short-chain fatty acids, and inflammatory molecules.26Fertility and Sterility Reviews. What Does PCOS Cause? Symptoms and Health Risks Studies comparing the gut bacteria of women with PCOS to healthy controls have found differences in specific bacterial populations, and some of these bacterial shifts correlate with androgen levels and inflammatory markers.27PubMed Central. Alterations of Gut Microbiome and Fecal Fatty Acids in Patients With Polycystic Ovary Syndrome in Central China – Section: RESULTS
This research is still early, and the direction of causation is not settled. It is entirely possible that the hormonal and metabolic disruptions of PCOS reshape the gut environment rather than the other way around, or that both processes feed each other. Probiotics and dietary interventions targeting gut health are being studied in PCOS, but it would be premature to call any of them proven treatments for the syndrome itself.
What Happens After Menopause
A common assumption is that PCOS “goes away” after menopause, since the ovaries wind down their activity. The reality is more complicated. A systematic review and meta-analysis of studies in perimenopausal and postmenopausal women with a history of PCOS found that excess androgen levels appeared to persist into the late reproductive years and beyond.28Human Reproduction Update. PCOS during the menopausal transition and after menopause: a systematic review and meta-analysis The cardiometabolic complications, particularly in women who also carry excess weight, tend to continue or even worsen with aging. That said, the evidence was noted to be heterogeneous and of overall low quality, so firm conclusions about the exact trajectory after menopause are still lacking.
For practical purposes, a history of PCOS should remain part of your medical profile through midlife and beyond. The cardiovascular, metabolic, and liver risks do not reset when periods stop.
A Surprising Upside for Bone Health
Not everything PCOS causes is harmful. A Mendelian randomization study using data from a large biobank found that the genetic risk profile associated with hyperandrogenism in PCOS was linked to higher bone mineral density and a modestly reduced risk of fractures in women.29PubMed Central / Elsevier / Bone. Genetic risk for the polycystic ovary syndrome, bone mineral density and fractures in women and men: A UK Biobank Mendelian randomisation study – Section: RESULTS Androgens are known to support bone density, so this finding aligns with the broader biology. It is a small silver lining, and it does not offset the metabolic and cardiovascular risks, but it is a real one.
An Evolutionary Puzzle
Given how many problems PCOS causes, it is natural to wonder why it persists in the population at all. Some researchers have proposed that the metabolic features of PCOS, particularly enhanced fat storage and insulin resistance, were advantages for survival during periods of food scarcity. The idea is that ancestral women who stored energy efficiently and ovulated less frequently may have invested more resources in fewer offspring, improving those children’s chances of survival.30PubMed Central. An Evolutionary Model for the Ancient Origins of Polycystic Ovary Syndrome31PubMed Central. Polycystic ovary syndrome as a plausible evolutionary outcome of metabolic adaptation In a world of caloric abundance, the same metabolic programming becomes a liability. This remains a hypothesis, but it offers an interesting framework for understanding why a syndrome that affects so many body systems has not been weeded out by natural selection.